Clinical Trial Update: T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors [NA]

View source ↗

Summary

A completed clinical trial update examining T-cell responses in HER2-positive solid tumors treated with trastuzumab and/or chemotherapy. The study NCT00433407 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer
• Sarcoma

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Breast Cancer, Lung Cancer | NA | Status: COMPLETED